C1QTNF6 and cancer: To assess the clinical significance of C1qtnf6 expression, we analyzed its association with patient outcomes across a pan‐cancer dataset using Cox regression analysis of 33 cancer types, evaluating survival measures, including overall survival (OS), disease‐specific survival (DSS), and progression‐free survival (PFS) (Figure 1C–E).